10-Q: Aimei Health Faces Going Concern Amid SPAC Merger Push

Aimei Health Technology Co., Ltd. reports significant redemptions and a going concern warning as it pushes to finalize its business combination with United Hydrogen Group Inc. by early 2026.

Summary

• The company, a blank check company (SPAC), reported a net income of $352,019 for the three months ended September 30, 2025, a decrease from $743,510 in the same period of 2024.
• For the nine months ended September 30, 2025, net income was $961,651, down from $2,108,102 for the nine months ended September 30, 2024.
• Cash held in the Trust Account significantly decreased to $45,443,570 as of September 30, 2025, from $73,784,549 at December 31, 2024, primarily due to shareholder redemptions.
• On February 5, 2025, 2,904,267 shares were redeemed by shareholders at approximately $10.77 per share, totaling about $31.27 million.
• The company's cash balance outside the Trust Account was $2,979 as of September 30, 2025, a sharp decline from $28,208 at December 31, 2024.
• A working capital deficit of $2,749,480 was reported as of September 30, 2025.
• Total liabilities increased to $3,464,428 as of September 30, 2025, from $1,506,994 at December 31, 2024, largely due to related party extension loans.
• The company has extended its deadline to consummate a business combination twelve times, now having until December 6, 2025.
• Shareholders approved the proposed business combination with United Hydrogen Group Inc. on November 6, 2025, with the closing expected in early 2026.
• Management has identified substantial doubt about the company's ability to continue as a going concern if the business combination is not completed within the prescribed period.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant financial deterioration, substantial shareholder redemptions, a 'going concern' warning, and increased liabilities. While the business combination has been approved and is expected to close, the underlying financial health and operational challenges present considerable risk.

Positives

• Shareholders approved the proposed business combination with United Hydrogen Group Inc. on November 6, 2025.
• The company expects to close the business combination in early 2026, indicating progress towards its primary objective.
• Formation and operating costs decreased to $130,152 for the three months ended September 30, 2025, from $200,019 in the prior year period, and to $585,170 for the nine months ended September 30, 2025, from $662,765 in the prior year period.

Negatives

• Net income significantly decreased to $352,019 for the three months ended September 30, 2025, from $743,510 in the prior year period.
• Net income for the nine months ended September 30, 2025, decreased to $961,651 from $2,108,102 in the prior year period.
• The cash held in the Trust Account declined substantially to $45,443,570 from $73,784,549, reflecting significant shareholder redemptions.
• The company reported a working capital deficit of $2,749,480 as of September 30, 2025.
• Total liabilities increased to $3,464,428, driven by a rise in related party extension loans to $1,655,400.
• The company's disclosure controls and procedures were deemed not effective as of September 30, 2025.
• Management has determined that there is substantial doubt about the company's ability to continue as a going concern if the business combination is not consummated.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern if it fails to consummate an initial business combination within the prescribed period, leading to liquidation.
• The Sponsor's ability to satisfy indemnity obligations for claims reducing the Trust Account below $10.10 per share is limited, as its only assets are believed to be company securities and no funds have been reserved for such obligations.
• The rights issued in connection with the Initial Public Offering may expire worthless if the company is unable to complete a business combination within the Combination Period and liquidates the Trust Account funds.

Future Outlook

The company expects to close its business combination with United Hydrogen Group Inc. in early 2026, contingent upon various conditions including shareholder approvals and regulatory clearances. The current deadline to consummate the business combination is December 6, 2025.

Management Comments

• We expect to close the business combination in early 2026, subject to various conditions, including shareholder approvals and regulatory clearances.
• Management has determined that if the Company is unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the Initial Public Offering, the requirement that the Company cease all operations, redeem the Public Shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern within one year after the date that the financial statements are issued.

Industry Context

Aimei Health Technology Co., Ltd. operates as a Special Purpose Acquisition Company (SPAC) targeting healthcare innovation. The significant redemptions and multiple extensions to the business combination deadline are common challenges faced by SPACs in the current market environment, often leading to reduced capital for the target business and increased pressure to complete a merger before liquidation. The 'going concern' warning highlights the inherent risks of the SPAC model when a definitive business combination is prolonged.

Comparison to Industry Standards

• The substantial redemption of 2,904,267 shares for approximately $31.27 million, reducing the Trust Account from $73.78 million to $45.44 million, is a significant capital outflow, a common trend among SPACs facing investor skepticism or market volatility, often seen in comparison to SPACs like Gores Holdings VI (GHVI) or Churchill Capital Corp IV (CCIV) which also experienced high redemption rates prior to their de-SPAC transactions.
• The need for twelve monthly extensions, funded by related party loans, to complete the business combination is indicative of a prolonged and challenging de-SPAC process, similar to other SPACs that have struggled to meet initial deadlines, such as those in the EV or clean energy sectors that faced increased scrutiny and market shifts.
• The 'going concern' disclosure is a critical red flag for SPACs that are nearing their dissolution deadline without a completed merger, placing Aimei Health in a precarious position comparable to other SPACs that ultimately liquidated due to an inability to find or close a suitable target.

Corporate Governance

Related Party Transactions

• Extension loans from the Sponsor and United Hydrogen Group Inc. totaling $1,655,400 as of September 30, 2025, evidenced by unsecured promissory notes.
• An amount of $826,419 is due to a related company (the Sponsor) as of September 30, 2025, for general and administrative services, IPO costs, and administrative services.
• The company pays the Sponsor $10,000 per month for administrative services, including office space and utilities, under an administrative services agreement.

Stakeholder Impact

• Shareholders who redeemed their shares received approximately $10.77 per share, while remaining shareholders face the risk associated with the 'going concern' warning and the successful completion of the business combination.
• The Sponsor and United Hydrogen Group Inc. have provided significant financial support through extension loans, indicating their continued commitment but also increasing their financial exposure to the company's success.
• Underwriters are awaiting a deferred fee of $690,000, which is contingent upon the closing of the business combination.

Next Steps

• Consummate the business combination with United Hydrogen Group Inc. by the extended deadline of December 6, 2025.
• Finalize the closing of the business combination with United Hydrogen Group Inc. in early 2026.

Key Dates

Recommendation

The company faces significant financial challenges, including a 'going concern' warning and substantial redemptions that have depleted its Trust Account. However, the recent shareholder approval of the business combination with United Hydrogen and the expectation of closing in early 2026 provide a potential catalyst for future value. Given the high risk but also the potential for a successful merger, a 'hold' recommendation is appropriate for investors who are already positioned, awaiting the outcome of the business combination. New investors should exercise extreme caution due to the inherent risks.

Keywords

SPAC, blank check company, business combination, United Hydrogen, redemptions, going concern, SEC filing, 10-Q, healthcare innovation, trust account